ExxonMobil (XOM)

Operating Expenses

$52.13B

TTM · Period ending: · USD

XOM logo

XOM Operating Expenses

Latest reported$52.13B
XOM TTM Operating Expenses ($62.04B → $52.13B)
High-resolution chart · PNG

XOM operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

ExxonMobil Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
52,133,000,000
53,730,000,000
36,295,000,000
36,656,000,000
36,499,000,000
36,763,000,000
37,090,000,000
36,861,000,000
38,050,000,000
38,895,000,000
39,681,000,000
40,526,000,000
39,116,000,000
38,655,000,000
39,039,000,000
39,931,000,000
41,168,000,000
41,751,000,000
40,867,000,000
40,000,000,000
39,618,000,000
37,128,000,000
37,575,000,000
38,634,000,000
39,378,000,000
42,436,000,000
43,192,000,000
43,259,000,000
44,018,000,000
44,883,000,000
45,609,000,000
48,379,000,000
47,559,000,000
46,297,000,000
44,906,000,000
40,699,000,000
39,591,000,000
38,914,000,000
38,176,000,000
38,641,000,000
39,354,000,000
39,704,000,000
40,289,000,000
41,222,000,000
42,682,000,000
44,720,000,000
46,553,000,000
47,867,000,000
48,294,000,000
48,045,000,000
48,083,000,000
35,733,000,000
35,419,000,000
36,584,000,000
39,497,000,000
57,806,000,000
64,541,000,000
69,916,000,000
72,620,000,000
51,518,000,000
50,295,000,000
47,804,000,000
46,772,000,000
73,656,000,000
79,507,000,000
78,517,000,000
76,816,000,000
68,201,000,000
72,543,000,000
76,481,000,000
79,701,000,000
82,513,000,000
72,007,000,000
77,590,000,000
75,903,000,000
104,947,000,000
104,208,000,000
96,215,000,000
102,937,000,000
71,838,000,000
72,661,000,000
72,667,000,000
66,209,000,000
67,006,000,000
65,860,000,000
64,980,000,000
64,570,000,000
63,689,000,000
62,767,000,000
61,776,000,000
60,088,000,000
57,777,000,000
56,110,000,000
55,192,000,000
54,181,000,000
54,453,000,000
54,633,000,000
54,072,000,000
54,221,000,000
53,559,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.